Home › Funds › Affinity Asset Advisors, LLC › ALKS
Affinity Asset Advisors, LLC position in ALKS
ALKERMES PLC · Health Care
Affinity Asset Advisors, LLC reported holding 615,400 shares of ALKS (ALKERMES PLC) in its Q3 2026 13F filing — a position valued at US$24.9M, representing 1.16% of its reported portfolio and ranking #25 among its reported holdings. Affinity Asset Advisors, LLC has disclosed ALKS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Affinity Asset Advisors, LLC's ALKS position evolved
Affinity Asset Advisors, LLC first disclosed a stake in ALKS in Q3 2023 at 100,000 shares (US$2.8M). The position peaked in Q1 2026 at 1,350,000 shares, worth US$47.7M. Across 13 filings, Affinity Asset Advisors, LLC increased the stake 7 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 615,400 shares valued at US$24.9M — an increase of 365,400 shares quarter over quarter.. Notable position changes include a 178% increase in Q1 2024 (shares fell 11% over the following quarter), a 767% increase in Q2 2024 (shares rose 16% over the following quarter), a 146% increase in Q3 2026 (shares rose 16% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 100.00K | $2.80M | New |
| Q4 2023 | 27.00K | $748.98K | Reduce |
| Q1 2024 | 75.00K | $2.03M | Add |
| Q2 2024 | 650.00K | $15.66M | Add |
| Q3 2024 | 1.00M | $27.99M | Add |
| Q4 2024 | 1.10M | $31.64M | Add |
| Q1 2025 | 1.00M | $33.02M | Reduce |
| Q2 2025 | 1.00M | $28.61M | Hold |
| Q3 2025 | 1.25M | $37.50M | Add |
| Q4 2025 | 1.00M | $27.98M | Reduce |
| Q1 2026 | 1.35M | $47.74M | Add |
| Q2 2026 | 250.00K | $13.10M | Reduce |
| Q3 2026 | 615.40K | $24.94M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ALKS and 13F data
ALKS (ALKERMES PLC) is a Health Care company. 38 other funds we track also report a position in ALKS — the largest reported positions include BAKER BROS. ADVISORS LP (US$524.6M), Renaissance Technologies (US$263.1M), Deep Track Capital, LP (US$209.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ALKS
- BAKER BROS. ADVISORS LP 10.01M sh · $524.59M · Q2 2026
- Renaissance Technologies 6.49M sh · $263.13M · Q3 2026
- Deep Track Capital, LP 4.00M sh · $209.58M · Q2 2026
- Commodore Capital LP 3.00M sh · $157.19M · Q2 2026
- BVF INC/IL 2.15M sh · $112.90M · Q2 2026
- Bain Capital Life Sciences Investors, LLC 1.94M sh · $101.54M · Q2 2026
- RTW INVESTMENTS, LP 1.67M sh · $87.62M · Q2 2026
- Soleus Capital Management, L.P. 1.03M sh · $53.93M · Q2 2026
More on Affinity Asset Advisors, LLC
FAQ
How long has Affinity Asset Advisors, LLC held ALKS?
Affinity Asset Advisors, LLC has disclosed ALKS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Affinity Asset Advisors, LLC's current position in ALKS?
As of Q3 2026, Affinity Asset Advisors, LLC holds 615.40K shares of ALKS (ALKERMES PLC), valued at $24.94M, representing 1.16% of its reported portfolio and ranking #25.
Has Affinity Asset Advisors, LLC been buying or selling ALKS?
In the latest 13F filing (Q3 2026), Affinity Asset Advisors, LLC increased its position in ALKS. The position peaked in Q1 2026 at 1.35M shares.
Which other funds hold ALKS?
Other major institutional holders of ALKS include BAKER BROS. ADVISORS LP, Renaissance Technologies, Deep Track Capital, LP, among 38 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.